Sep 9 2009
IntrinsiQ president Jeff Forringer will discuss clinical oncology treatment guidelines – and what drives variations from the standard-of-care – at the 6th Annual ICORE/Magellan Oncology Summit this Friday in New York.
As the economics of chemotherapy have fundamentally changed within the past five years, Forringer has been tapped to share his insights into today’s clinical cancer care process, and how physicians’ treatment decisions impact healthcare costs nationwide. His presentation will draw from IntrinsiQ’s unmatched insight into the treatment decisions of oncologists nationwide to show how doctors truly practice, the factors that bear the greatest influence on outcomes and costs, and how private practices differ from hospital settings.
The Summit is designed to address participant questions with panels comprised of nationally recognized payors, policy-makers and oncologists, who will address the key issues facing the oncology specialty in 2009 and beyond.
http://www.intrinsiq.com/
Rare genetic mutations in healthy women may be key to breast cancer origins